TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33250211

Group type: EXPERIMENTAL
Intervention: Sowing of native perennial grass seed (Anthephora pubescens, Chloris gayana, Cynodon dactylon, Digitaria eriantha, Eragrostis curvula, Panicum maximum, Themeda triandra)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Clearing of Parthenium hysterophorus
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Sowing of native perennial grass seed
Number of subjects: 48
Study: 33048154

Group type: EXPERIMENTAL
Intervention: Intensive treatment (n=153) with 4 weekly, 4 biweekly, and 3 monthly counseling sessions and choice of cessation medication.
Number of subjects: 303

Group type: COMPARATOR
Intervention: Standard treatment (n=150) with 4 weekly counseling sessions and medication advice.
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Intensive treatment (n=153) participants reporting cessation medication use.
Number of subjects: 303

Group type: COMPARATOR
Intervention: Standard treatment (n=150) participants reporting cessation medication use.
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Intensive treatment group adverse events (n=153).
Number of subjects: 303

Group type: COMPARATOR
Intervention: Standard treatment group adverse events (n=150).
Number of subjects: 303
Study: 35718070

Group type: EXPERIMENTAL
Intervention: Gastrointestinal Endoscopy AI‐assisted Diagnosis System (GEADS)
Number of subjects: 105573

Group type: COMPARATOR
Intervention: Endoscopists (novice and expert)
Number of subjects: 105573
Study: 32981714

Group type: EXPERIMENTAL
Intervention: Increase in occlusal vertical dimension (OVD) by 3, 6, and 9 mm
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Increase in occlusal vertical dimension (OVD) by 3 mm
Number of subjects: 25

Group type: COMPARATOR
Intervention: Original OVD
Number of subjects: 25
Study: 33002440

Group type: EXPERIMENTAL
Intervention: Ivosidenib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32441857

Group type: EXPERIMENTAL
Intervention: Buspirone (15 mg thrice daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 16
Study: 35550374

Group type: EXPERIMENTAL
Intervention: Intrarectal 10-mg diazepam suppository
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 33596099

Group type: EXPERIMENTAL
Intervention: Hope enhancement workshop (half-day)
Number of subjects: 39
Study: 32689594

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 15mg daily
Number of subjects: 7213

Group type: COMPARATOR
Intervention: Aspirin 100mg daily
Number of subjects: 7213
Study: 35813411

Group type: EXPERIMENTAL
Intervention: Predictive nursing combined with early drinking water therapy
Number of subjects: 600

Group type: COMPARATOR
Intervention: Routine nursing (Control)
Number of subjects: 600
Study: 33478236

Group type: EXPERIMENTAL
Intervention: Bilateral internal mammary artery grafts (n = 387)
Number of subjects: 772

Group type: COMPARATOR
Intervention: Left internal mammary artery grafts (n = 385)
Number of subjects: 772
Study: 35729430

Group type: EXPERIMENTAL
Intervention: Canagliflozin (100 mg, n=113)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Glimepiride (starting dose: 0.5 mg, n=120)
Number of subjects: 233
Study: 33499076

Group type: EXPERIMENTAL
Intervention: Oral hygiene board game intervention (60-min sessions, twice a week)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control stage (pre-test and baseline measurements)
Number of subjects: 42
Study: 35176533

Group type: EXPERIMENTAL
Intervention: CALAS 20 mg three times daily for seven days
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: CALAS 40 mg three times daily for seven days
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: CALAS 80 mg three times daily for seven days
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 32728702

Group type: EXPERIMENTAL
Intervention: Acute alcohol consumption
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 35691184

Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: TNES
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study: 32781283

Group type: EXPERIMENTAL
Intervention: Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules combined with western medicine
Number of subjects: 283

Group type: COMPARATOR
Intervention: Lianhua Qingwen granules combined with western medicine
Number of subjects: 283

Group type: COMPARATOR
Intervention: Western medicine alone
Number of subjects: 283
Study: 35435017

Group type: EXPERIMENTAL
Intervention: Low sodium diet (<2 g of sodium)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 98
Study: 34477291

Group type: EXPERIMENTAL
Intervention: Home Treatment (HT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Inpatient Treatment-as-Usual (TAU)
Number of subjects: 100
Study: 32894190

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (TA)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Medication (MC)
Number of subjects: 105
Study: 34313948

Group type: EXPERIMENTAL
Intervention: Cryoneurolysis
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study: 35175622

Group type: EXPERIMENTAL
Intervention: CBD25 (25 mg/kg/day)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: CBD50 (50 mg/kg/day)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study: 33026876

Group type: EXPERIMENTAL
Intervention: Celebrate Safe approach (experimental condition)
Number of subjects: 3836

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 3836
Study: 32047014

Group type: EXPERIMENTAL
Intervention: HELP‐CDSS (computerised clinical decision support system)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control period (standard care)
Number of subjects: 135
Study: 36255525

Group type: COMPARATOR
Intervention: 0.125% levobupivacaine at 8 mL/h
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 0.25% levobupivacaine at 8 mL/h
Number of subjects: 50
Study: 33395687

Group type: EXPERIMENTAL
Intervention: Continuous Theta-Burst Stimulation (cTBS)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intermittent Theta-Burst Stimulation (iTBS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 28
Study: 33850624

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 35889936

Group type: COMPARATOR
Intervention: Isotretinoin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Isotretinoin and evening primrose oil
Number of subjects: 50
Study: 33502815

Group type: EXPERIMENTAL
Intervention: VERVE Chews Blue Mint
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VERVE Chews Green Mint
Number of subjects: 0

Group type: COMPARATOR
Intervention: CIGS (own-brand cigarettes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: GUM (nicotine polacrilex gum)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Test products (VERVE Chews)
Number of subjects: 0
Study: 33523128

Group type: COMPARATOR
Intervention: Prospective audit and feedback (PAF)
Number of subjects: 429062

Group type: COMPARATOR
Intervention: Restrictive policies (RP)
Number of subjects: 429062

Group type: COMPARATOR
Intervention: No strategy (NS)
Number of subjects: 429062

Group type: COMPARATOR
Intervention: ID consultations
Number of subjects: 429062
Study: 35287788

Group type: EXPERIMENTAL
Intervention: Apolla Performance Shock™ dance socks (DS)
Number of subjects: 21
Study: 34488701

Group type: EXPERIMENTAL
Intervention: Antipsychotics (AP) withdrawal (pipamperone or risperidone); dose reduced by 25% every 4 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group); dose remains unaltered.
Number of subjects: 0
Study: 32957204

Group type: EXPERIMENTAL
Intervention: Conical implants
Number of subjects: 25

Group type: COMPARATOR
Intervention: Straight implants
Number of subjects: 25
Study: 33593279

Group type: EXPERIMENTAL
Intervention: High leisure-time physical activity (LTPA)
Number of subjects: 761

Group type: COMPARATOR
Intervention: Low leisure-time physical activity (LTPA)
Number of subjects: 761
Study: 32420318

Group type: EXPERIMENTAL
Intervention: PCV+OLA
Number of subjects: 176

Group type: COMPARATOR
Intervention: PCV
Number of subjects: 176
Study: 35577644

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (5-fluorouracil and mitomycin C with radiotherapy)
Number of subjects: 458
Study: 34280472

Group type: EXPERIMENTAL
Intervention: miR‐185‐5p and miR‐425‐5p expression levels measured before radiation therapy
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: miR‐185‐5p and miR‐425‐5p expression levels measured after 20 Gy
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Model including pretreatment miR‐185‐5p and miR‐425‐5p levels with mean parotid dose
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: miR‐185‐5p and miR‐425‐5p levels after 20 Gy with mean parotid dose
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: miR‐185‐5p and miR‐425‐5p levels after 20 Gy
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Model application in validation cohort
Number of subjects: 111
Study: 34081897

Group type: EXPERIMENTAL
Intervention: DNA-based assays (Digene Hybrid Capture 2 High-Risk HPV DNA Test and cobas 4800 HPV Test)
Number of subjects: 12982

Group type: COMPARATOR
Intervention: RNA-based assay (Aptima HPV Assay)
Number of subjects: 12982
Study: 34806780

Group type: EXPERIMENTAL
Intervention: Professional-mode flash glucose monitoring
Number of subjects: 299

Group type: COMPARATOR
Intervention: Usual clinical care
Number of subjects: 299
Study: 34368045

Group type: EXPERIMENTAL
Intervention: Video intervention
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control
Number of subjects: 98
Study: 33565656

Group type: EXPERIMENTAL
Intervention: Autogenous whole tooth (AWTG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Autogenous demineralized dentin graft (ADDG)
Number of subjects: 20
Study: 34269160

Group type: EXPERIMENTAL
Intervention: Thoracic spine manipulation (TSM)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No treatment (Hold)
Number of subjects: 48
Study: 33779542

Group type: EXPERIMENTAL
Intervention: Neck circumference/height ratio (NHR) cut point ≥ 0.21
Number of subjects: 6167

Group type: EXPERIMENTAL
Intervention: Waist circumference/height ratio (WHR) cut point ≥ 0.52
Number of subjects: 6167

Group type: EXPERIMENTAL
Intervention: NHR, WHR, and derived STOP‐Bang Questionnaire (dSBQ) areas under the receiver operator curves
Number of subjects: 6167

Group type: COMPARATOR
Intervention: Comparison of NHR and dSBQ areas under the receiver operator curves
Number of subjects: 6167

Group type: COMPARATOR
Intervention: Comparison of WHR and dSBQ areas under the receiver operator curves
Number of subjects: 6167
Study: 35363163

Group type: EXPERIMENTAL
Intervention: Sauti ya Vijana (SYV) mental health intervention
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 21
Study: 34163141

Group type: COMPARATOR
Intervention: 25 mg tenofovir alafenamide tablets (test formulation)
Number of subjects: 74
Study: 32800407

Group type: EXPERIMENTAL
Intervention: Prophylactic mesh
Number of subjects: 242

Group type: COMPARATOR
Intervention: Conventional stoma construction (Control)
Number of subjects: 242
Study: 36331152

Group type: EXPERIMENTAL
Intervention: High-protein diet combined with exercise
Number of subjects: 13

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 13
Study: 32228534

Group type: EXPERIMENTAL
Intervention: Bespoke communication training for health professionals
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Health professionals' presentation of treatment arms
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Qualitative analysis of recruitment consultations
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Interviews with families
Number of subjects: 58
Study: 34030517

Group type: EXPERIMENTAL
Intervention: SuperPATH approach
Number of subjects: 44

Group type: COMPARATOR
Intervention: MPA approach
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 44
Study: 34002007

Group type: EXPERIMENTAL
Intervention: Moderate to vigorous physical activity
Number of subjects: 157

Group type: COMPARATOR
Intervention: Sedentary or light physical activity
Number of subjects: 157
Study: 32295773

Group type: EXPERIMENTAL
Intervention: HABIT (habit formation of parental support)
Number of subjects: 240

Group type: COMPARATOR
Intervention: PLANNING (planning and education group)
Number of subjects: 240

Group type: COMPARATOR
Intervention: EDUCATION (education only group)
Number of subjects: 240
Study: 36002221

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Cervical pessary
Number of subjects: 960

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 960
Study: 34814893

Group type: EXPERIMENTAL
Intervention: Educational program based on Theory of Planned Behavior (TPB) conducted in six educational sessions.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Routine education about lifestyle changes including osteoporosis.
Number of subjects: 64
Study: 32183810

Group type: EXPERIMENTAL
Intervention: Structured drug review using the STRIP method assisted by a clinical decision support system (STRIP Assistant, STRIPA) with integrated STOPP/START criteria (version 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Structured drug review
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical decision support system (CDSS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: STOPP/START criteria application
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-component intervention
Number of subjects: 0
Study: 35148407

Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation + Respiratory-Gated Auricular Vagal Afferent Nerve Stimulation (MM+RAVANS)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Mindfulness Meditation + Sham Stimulation (MM+Sham)
Number of subjects: 19
Study: 32985121

Group type: EXPERIMENTAL
Intervention: NeuroSAFE RARP
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard RARP
Number of subjects: 49
Study: 32232885

Group type: EXPERIMENTAL
Intervention: Consolidated therapy group (CTG) with balneotherapy and Chinese herbal medicine (CHM)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Unconsolidated therapy group (UTG)
Number of subjects: 200
Study: 34475270

Group type: EXPERIMENTAL
Intervention: Large monthly cash gift
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Nominal monthly cash gift
Number of subjects: 1000
Study: 35960650

Group type: EXPERIMENTAL
Intervention: ses-IgE-based predictor
Number of subjects: 331
Study: 34008228

Group type: EXPERIMENTAL
Intervention: Cold pack applied for 6 hours post-operation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard postoperative care
Number of subjects: 100
Study: 32482669

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) therapy associated with supervised therapeutic exercises (STEP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Supervised therapeutic exercises (STEP) alone
Number of subjects: 120
Study: 35815057

Group type: EXPERIMENTAL
Intervention: Home-based cardiac rehabilitation (long-distance family rehabilitation nursing intervention)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional outpatient rehabilitation (control group)
Number of subjects: 80
Study: 32737637

Group type: EXPERIMENTAL
Intervention: Open total gastrectomy (OTG)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Minimally invasive total gastrectomy (MITG)
Number of subjects: 96
Study: 34341046

Group type: EXPERIMENTAL
Intervention: Peer-befriending intervention
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Usual care + peer-befriending
Number of subjects: 28

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 28
Study: 32057962

Group type: EXPERIMENTAL
Intervention: 30-min plasma glucose measurement during OGTT
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: 30-min plasma glucose >182 mg/dl
Number of subjects: 548
Study: 34952123

Group type: EXPERIMENTAL
Intervention: Quetiapine (300 mg/day)
Number of subjects: 770

Group type: COMPARATOR
Intervention: Lithium (two different doses)
Number of subjects: 770

Group type: COMPARATOR
Intervention: Standard treatment without lithium
Number of subjects: 770
Study: 33733337

Group type: EXPERIMENTAL
Intervention: Radiomics model combined with clinical factors
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: 2 mm peritumoral radiomics model
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: 5 mm peritumoral radiomics model
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Tumoral radiomics model
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Combined T + PT model
Number of subjects: 153
Study: 33155169

Group type: EXPERIMENTAL
Intervention: NLP algorithm for abstracting MPI reports
Number of subjects: 16957

Group type: COMPARATOR
Intervention: Patients with abnormal MPI results
Number of subjects: 16957
Study: 34154603

Group type: EXPERIMENTAL
Intervention: 12 mg Capsiate (CAP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 20
Study: 32757317

Group type: EXPERIMENTAL
Intervention: 800 IU daily of cholecalciferol
Number of subjects: 50

Group type: COMPARATOR
Intervention: 400 IU daily of cholecalciferol (Control)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Serum 25(OH) vitamin D
Number of subjects: 50
Study: 35490873

Group type: EXPERIMENTAL
Intervention: GDMT titrated to achieve NT-proBNP <1000 pg/mL
Number of subjects: 894

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 894
Study: 33551349

Group type: EXPERIMENTAL
Intervention: PPI alone
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: PPI + rebamipide
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: H2RA + rebamipide
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 156
Study: 35245225

Group type: EXPERIMENTAL
Intervention: Scalpel-Finger-Cannula (SFC)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Scalpel-Finger-Bougie (SFB)
Number of subjects: 65
Study: 36204783

Group type: EXPERIMENTAL
Intervention: Ozone therapy
Number of subjects: 53
Study: 34193622

Group type: EXPERIMENTAL
Intervention: Ergonomic infant carrier and instruction on proper use
Number of subjects: 100

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 100
Study: 32289715

Group type: EXPERIMENTAL
Intervention: High-frequency (20 Hz) unilateral rTMS over the left DLPFC
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 100
Study: 36030457

Group type: EXPERIMENTAL
Intervention: 5-week HRV biofeedback intervention
Number of subjects: 165
Study: 32965802

Group type: EXPERIMENTAL
Intervention: Low-dose furosemide (2.5 mg/kg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: High-dose furosemide (5 mg/kg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 21
Study: 32883286

Group type: EXPERIMENTAL
Intervention: Ultra-sensitive HRP2-based Alere™ Malaria Ag P.f RDT (uRDT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel algorithm using HRP2:pLDH ratios
Number of subjects: 0
Study: 34984794

Group type: EXPERIMENTAL
Intervention: linagliptin 5 mg once daily for 8 days
Number of subjects: 29
Study: 34518314

Group type: EXPERIMENTAL
Intervention: Rescube tool with a cuddly toy (n = 61)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Endless Book tool with a cuddly toy (n = 74)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Traditional teaching with a cuddly toy (n = 46)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Traditional teaching with a manikin (n = 55)
Number of subjects: 237
Study: 32397609

Group type: EXPERIMENTAL
Intervention: ProBeptigen®
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 36427543

Group type: EXPERIMENTAL
Intervention: Cottonseed oil (CSO) diet
Number of subjects: 42

Group type: COMPARATOR
Intervention: Olive oil (OO) diet
Number of subjects: 42
Study: 33657998

Group type: EXPERIMENTAL
Intervention: Mulligan Manual Therapy (MMT) and exercise
Number of subjects: 297

Group type: COMPARATOR
Intervention: Placebo and exercise
Number of subjects: 297

Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 297
Study: 36178575

Group type: EXPERIMENTAL
Intervention: Lymph node dissections (LNDs) ≥ 10
Number of subjects: 26517

Group type: COMPARATOR
Intervention: Lymph node dissections (LNDs) ≤ 9
Number of subjects: 26517
Study: 35725141

Group type: EXPERIMENTAL
Intervention: Daily physical activity promotion text messages
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (1 neutral message related to general health information weekly)
Number of subjects: 0
Study: 36111824

Group type: EXPERIMENTAL
Intervention: iN2L tablets and access to Alzheimer's Association supportive programs
Number of subjects: 124
Study: 34730890

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (800 IU in drops for three months)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (no vitamin D supplementation)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 97
Study: 32544125

Group type: EXPERIMENTAL
Intervention: Panic Control Therapy (PCT)
Number of subjects: 66

Group type: COMPARATOR
Intervention: PCT and in vivo exposures to agoraphobic situations (PCT + IV)
Number of subjects: 66
Study: 34511168

Group type: EXPERIMENTAL
Intervention: Alfacalcidol (0.25 μg/d) for 4 weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (vitamin C, rutin tablets, dipyridamole, cimetidine, calcium supplements, glucocorticoids)
Number of subjects: 200